Digital mHealth and Virtual Care Use During COVID-19 in 4 Countries: Rapid Landscape Review
Open accessPublished version of a preprint
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Background: As a result of the COVID-19 pandemic, providing health care while maintaining social distancing has resulted in the need to provide care remotely, support quarantined or isolated individuals, monitor infected individuals and their close contacts, as well as disseminate accurate information regarding COVID-19 to the public. This has led to an unprecedented rapid expansion of digital tools to provide digitized virtual care globally, especially mobile phone–facilitated health interventions, called mHealth. To help keep abreast of different mHealth and virtual care technologies being used internationally to facilitate patient care and public health during the COVID-19 pandemic, we carried out a rapid investigation of solutions being deployed and considered in 4 countries. Objective: The aim of this paper was to describe mHealth and the digital and contact tracing technologies being used in the health care management of the COVID-19 pandemic among 2 high-income and 2 low-middle income countries. Methods: We compared virtual care interventions used for COVID-19 management among 2 high-income countries (the United Kingdom and Canada) and 2 low-middle income (Kenya and Rwanda) countries. We focused on interventions used to facilitate patient care and public health. Information regarding specific virtual care technologies was procured from a variety of resources including gray literature, government and health organization websites, and coauthors’ personal experiences as implementers of COVID-19 virtual care strategies. Search engine queries were performed to find health information that would be easily accessible to the general public, with keywords including “COVID-19,” “contact-tracing,” “tool-kit,” “telehealth,” and “virtual care,” in conjunction with corresponding national health authorities. Results: We identified a variety of technologies in Canada, the United Kingdom, Rwanda, and Kenya being used for patient care and public health. These countries are using both video and text message–based platforms to facilitate communication with health care providers (eg, WelTel and Zoom). Nationally developed contact tracing apps are provided free to the public, with most of them using Bluetooth-based technology. We identified that often multiple complimentary technologies are being utilized for different aspects of patient care and public health with the common purpose to disseminate information safely. There was a negligible difference among the types of technologies used in both high-income and low-middle income countries, although the latter implemented virtual care interventions earlier during the pandemic’s first wave, which may account for their effective response. Conclusions: Virtual care and mHealth technologies have evolved rapidly as a tool for health care support for both patient care and public health. It is evident that, on an international level, a variety of mHealth and virtual care interventions, often in combination, are required to be able to address patient care and public health concerns during the COVID-19 pandemic, independent of a country’s economic standing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but did not assess system-wide impacts [17, 18]”
From Telemedicine implementation and healthcare utilization in Rwanda: interrupted time series of Babyl digital health services from 2015 to 2024 (2026) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early evaluations documented high user satisfaction and clinical appropriateness for common conditions”
From Telemedicine implementation and healthcare utilization in Rwanda: interrupted time series of Babyl digital health services from 2015 to 2024 (2026) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamine, S., Gerth-Guyette, E., Faulx, D., Green, B. B., & Ginsburg, A. S. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.3951 · Cited by 1,149
Kvedar, J., Coye, M. J., & Everett, W. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.0992 · Cited by 629
Patient Satisfaction with Physician–Patient Communication During Telemedicine
Agha, Z., Schapira, R. M., Laud, P. W., McNutt, G., & Roter, D. L. (2009) · Telemedicine and e-Health · doi:10.1089/tmj.2009.0030 · Cited by 252
Challenges for NHS hospitals during covid-19 epidemic
Willan, J., King, A. J., Jeffery, K., & Bienz, N. (2020) · BMJ · doi:10.1136/bmj.m1117 · Cited by 251
Story, A., Aldridge, R. W., Smith, C. M., Garber, E., Hall, J., Ferenando, G., Possas, L., Hemming, S., Wurie, F., Luchenski, S., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32993-3 · Cited by 213
Self-citationTelemedicine is as effective as in-person visits for patients with asthma
Portnoy, J. M., Waller, M., De Lurgio, S., & Dinakar, C. (2016) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2016.07.012 · Cited by 195
Buchanan, A. H., Datta, S. K., Skinner, C. S., Hollowell, G. P., Beresford, H. F., Freeland, T., Rogers, B., Boling, J., Marcom, P. K., & Adams, M. B. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9836-6 · Cited by 181
Telehomecare: Quality, Perception, Satisfaction
Finkelstein, S. M., Speedie, S. M., Demiris, G., Veen, M., Lundgren, J. M., & Potthoff, S. (2004) · Telemedicine Journal and e-Health · doi:10.1089/1530562041641219 · Cited by 130
A critical evaluation of glucocorticoids in the management of severe COVID-19
Solinas, C., Perra, L., Aiello, M. M., Migliori, E., & Petrosillo, N. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.012 · Cited by 118
Vest, J. R., Kern, L. M., Silver, M. D., Kaushal, R., & for the HITEC investigators (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002760 · Cited by 106
Research works printed but not linked: 3
- Clarisse, M, 2020, Rw Public Health Bul 2020, 2, 7
- Breltenbach, M, 2020, MPRA Paper No. 101440, 1
- 10.1089/tmj.2004.10.122 · doi:10.1089/tmj.2004.10.122 · Paper page
Cited by
Rubuga, F. K., Absolomon, G., Uhawenimana, T. C., Nsaba-Uwera, Y. D., Muhire, J., Hagenimana, J. D., Nyabyenda, E. C., Irakiza, P., Semakula, M., Remera, E., et al. (2026) · BMC Primary Care · doi:10.1186/s12875-026-03179-8 · Cited by 1
“Early evaluations documented high user satisfaction and clinical appropriateness for common conditions but did not assess system-wide impacts [17, 18].”
Self-citation
Metadata
- Authors
- Müller, A., Cau, A., Muhammed, S., Abdullahi, O., Hayward, A., Nsanzimana, S., & Lester, R.
- Affiliations
- University of British Columbia (CA)
- Vancouver General Hospital (CA)
- ORCID
- Venue
- JMIR Formative Research
- Publisher
- JMIR Publications Inc.
- Published
- 2022-11-30
- Volume
- 6
- Issue
- 11
- Pages
- e26041
- ISSN
- 2561-326X (ISSN-L)
- PMC
- PMC9714961
- OpenAlex
- W3205613401
- Cited by
- 14
- References
- 21
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 5
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Formative Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Grand Challenges Canada
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Physical Sciences › Computer Science › Information Systems › COVID-19 Digital Contact Tracing
- Keywords
- COVID-19 pandemic, telemedicine, contact tracing apps, public health communication, low- and middle-income countries, high-income countries, Kenya, Rwanda, United Kingdom, Canada, health information dissemination, social distancing, digital health interventions, Zoom
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
